Shengwu Ma

Title: Innovations of Shengwu Ma in Plant Biotechnology

Introduction

Shengwu Ma is a notable inventor based in London, Canada, recognized for his contributions to plant biotechnology. He holds 2 patents that focus on innovative methods for producing transgenic proteins and controlling immune responses in mammals.

Latest Patents

One of his latest patents involves plant bioreactors, specifically a plant expressing a cytokine and an autoantigen. This invention includes a contra-inflammatory cytokine, such as IL-4 and IL-10, and an autoantigen like GAD. The patent also discloses a novel method for producing transgenic proteins suitable for oral administration. Furthermore, it describes non-food crop plants that express one or more proteins of interest, including pharmaceutically active proteins such as insulin and antibodies. The method ensures that the non-food crop plants are non-toxic, palatable, and require minimal processing prior to oral administration.

Career Highlights

Shengwu Ma has worked with reputable organizations, including the London Health Sciences Centre and the Government of Canada, represented by the Minister of Agriculture and Agri-Food. His work has significantly advanced the field of plant biotechnology, particularly in the area of transgenic protein production.

Collaborations

He has collaborated with notable individuals in his field, including Anthony Jevnikar and Calvin R. Stiller. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Shengwu Ma's work in plant biotechnology showcases his commitment to advancing scientific knowledge and developing practical applications for health and agriculture. His patents reflect a significant step forward in the production of transgenic proteins and the management of immune responses.